Mantle Cell Lymphoma
Mantle Cell Lymphoma (MCL) is a rare type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It can lead to symptoms such as swollen lymph nodes, fever, and weight loss.
Genetically Modified T-Cells for ROR1 Positive Tumors
We are assessing the safety and tolerability of a new treatment using genetically modified T-cells for patients with ROR1 positive tumors. This study aims to understand how these cells may help in treating this type of cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Ovarian Cancer
Ovarian cancer is a type of cancer that begins in the ovaries and can cause symptoms like abdominal bloating, pelvic pain, and changes in bowel habits. Early detection is crucial for effective treatment.
Adrenocortical Carcinoma
Adrenocortical carcinoma is a rare cancer that originates in the adrenal glands, which produce hormones. Symptoms may include abdominal pain, weight gain, and hormonal imbalances.
Breast Cancer
Breast cancer is a common cancer that forms in the cells of the breasts. It can present with symptoms such as a lump in the breast, changes in breast shape, or discharge from the nipple.
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to an overproduction of lymphocytes. Symptoms may include fatigue, swollen lymph nodes, and frequent infections.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Wuerzburg AöR
Medizinische Klinik und Poliklinik II, Interdisziplinäres Studienzentrum mit ECTU
Würzburg, Germany
Sponsor: Universitaetsklinikum Wuerzburg AöR
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.